HIF-1α and miR-210 differential and lineage-specific expression in systemic lupus erythematosus.
HIF-1α and miR-210 differential and lineage-specific expression in systemic lupus erythematosus.
复制标题
DOI:
10.1016/j.molimm.2021.02.019
复制
发表时间:
2021-05
影响因子:
3.6
通讯作者:
Kiriakidou M
中科院分区:
文献类型:
--
作者:
Garchow B;Maque Acosta Y;Kiriakidou M
Systemic lupus erythematosus (SLE, lupus) is a chronic autoimmune disease characterized by loss of peripheral tolerance to nuclear self-antigens. It is increasingly recognized that aberrant T cell metabolism is a critical mediator of SLE immunopathology. Hypoxia inducible factor 1α (HIF-lα) is a key transcription factor that regulates T cell metabolism in response to immune stimuli. T cell activation induces HIF-1α expression and transcriptional activation of HIF-responsive genes. HypoxamiRs are a group of microRNAs sensitive to HIF-1α transcriptional regulation that function to fine-tune the HIF-driven transcriptional program. The ‘master’ hypoxamiR, miR-210 is transcriptionally regulated by HIF-1α and negatively regulates HIF-1α activity. Although a key role for HIF-1α in has been described in a number of autoimmune and inflammatory diseases and abnormal microRNA expression profiles correlate with poor clinical outcome in a number of rheumatologic diseases, the expression and function of HIF-1α and miR-210 in lupus remains largely uncharacterized. Here we report HIF-1α and miR-210 differential and lineage-specific expression in systemic lupus erythematosus. We show that HIF-1α mRNA and protein is overexpressed in human lupus CD4+ cells but not in CD8+ or CD19+ cells. RORγt, was upregulated in human lupus lymphocytes while FoxP3 expression remained unchanged. We show that miR-210 expression in lupus-prone mice correlates with disease activity and is robustly and selectively upregulated in CD4+ cells from both human lupus patients and lupus-prone mice. Our results suggest that abnormal HIF-1α and miR-210 expression contributes to SLE immune pathology and that HIF-1α/miR-210 may represent a novel and important regulatory axis in SLE.
登录
查看更多内容
影响因子:
32.4
作者:
Palazon, Asis;Goldrath, Ananda W.;Nizet, Victor;Johnson, Randall S.
通讯作者:
Johnson, Randall S.
影响因子:
4.6
作者:
Del Rey MJ;Valín Á;Usategui A;García-Herrero CM;Sánchez-Aragó M;Cuezva JM;Galindo M;Bravo B;Cañete JD;Blanco FJ;Criado G;Pablos JL
通讯作者:
Pablos JL
影响因子:
6.4
作者:
Graumann, U;Reynolds, R;Schaeren-Wiemers, N
通讯作者:
Schaeren-Wiemers, N
影响因子:
2.1
作者:
Huang, Q.;Chen, S. -S.;Ye, D. -Q.
通讯作者:
Ye, D. -Q.
影响因子:
64.5
作者:
Dang EV;Barbi J;Yang HY;Jinasena D;Yu H;Zheng Y;Bordman Z;Fu J;Kim Y;Yen HR;Luo W;Zeller K;Shimoda L;Topalian SL;Semenza GL;Dang CV;Pardoll DM;Pan F
通讯作者:
Pan F